Somatropin biosimilar (Chalver Laboratorios)

生长激素生物类似药 (Chalver Laboratorios)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin biosimilar (Chalver Laboratorios)
Drug Alias Name生长激素生物仿制药 (Chalver Laboratorios)Human growth hormone analogBiotropin
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsGrowth hormone deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryColombia
Original Approved Date2012/10/01
Country/TerritoryColombia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChalver Laboratorios
China Registration ClassN/A

Develop Information

Active CompaniesChalver Laboratorios
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksN/A